Framework demonstrating dynamic transitions in liver disease types, suggesting new understanding of their relationship.
Introduction Steatotic liver disease (SLD) is an umbrella term mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-associated liver disease (MetALD) and alcohol-associated liver disease (ALD).
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: